Avidity Partners Management LP 13D and 13G filings for Kezar Life Sciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 06:50 am Sale | 2023-12-31 | 13G | Kezar Life Sciences, Inc. KZR | Avidity Partners Management LP | 502,545 6.900% | -175,695 (-25.90%) | Filing |
| 2023-02-14 3:44 pm Purchase | 2022-12-31 | 13G | Kezar Life Sciences, Inc. KZR | Avidity Partners Management LP | 678,240 9.900% | 355,420 (+110.10%) | Filing |
| 2022-01-03 12:09 pm Purchase | 2021-12-30 | 13G | Kezar Life Sciences, Inc. KZR | Avidity Partners Management LP | 322,820 6.600% | 322,820 (New Position) | Filing |